ANTARES PHARMA INC's ticker is ATRS and the CUSIP is 036642106. A total of 85 filers reported holding ANTARES PHARMA INC in Q2 2015. The put-call ratio across all filers is 0.15 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2022 | $136,000 | +22.5% | 33,238 | +6.6% | 0.00% | – |
Q4 2021 | $111,000 | +19.4% | 31,184 | +22.0% | 0.00% | -100.0% |
Q3 2021 | $93,000 | +3.3% | 25,560 | +23.3% | 0.00% | – |
Q2 2021 | $90,000 | +25.0% | 20,735 | +17.6% | 0.00% | – |
Q1 2021 | $72,000 | +26.3% | 17,634 | +22.6% | 0.00% | – |
Q4 2020 | $57,000 | +90.0% | 14,386 | -18.4% | 0.00% | – |
Q3 2015 | $30,000 | +172.7% | 17,634 | +225.8% | 0.00% | – |
Q2 2015 | $11,000 | +10.0% | 5,413 | +50.7% | 0.00% | – |
Q1 2015 | $10,000 | +11.1% | 3,592 | +1.0% | 0.00% | – |
Q4 2014 | $9,000 | +28.6% | 3,557 | -8.0% | 0.00% | – |
Q3 2014 | $7,000 | -36.4% | 3,866 | -9.5% | 0.00% | – |
Q2 2014 | $11,000 | -21.4% | 4,273 | +4.9% | 0.00% | – |
Q1 2014 | $14,000 | -22.2% | 4,075 | +1.0% | 0.00% | – |
Q4 2013 | $18,000 | -67.9% | 4,034 | -70.5% | 0.00% | – |
Q3 2013 | $56,000 | +86.7% | 13,694 | +89.0% | 0.00% | – |
Q2 2013 | $30,000 | – | 7,244 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Sargent Investment Group, LLC | 3,096,355 | $8,422,000 | 5.18% |
JW Asset Management, LLC | 1,920,524 | $5,224,000 | 3.85% |
Healthcare Value Capital, LLC | 250,000 | $680,000 | 2.64% |
ARMISTICE CAPITAL, LLC | 10,300,000 | $28,016,000 | 2.12% |
Broadfin Capital, LLC | 3,444,147 | $9,368,000 | 1.23% |
PERKINS CAPITAL MANAGEMENT INC | 409,000 | $1,112,000 | 0.86% |
MYCIO WEALTH PARTNERS, LLC | 1,896,500 | $5,158,000 | 0.48% |
ESSEX INVESTMENT MANAGEMENT CO LLC | 1,012,600 | $2,754,000 | 0.22% |
FALCON POINT CAPITAL, LLC | 130,200 | $354,000 | 0.21% |
Brown Advisory Securities, LLC | 275,000 | $781,000 | 0.15% |